Chemokines, molecular drivers of thromboinflammation and immunothrombosis

被引:16
作者
Leberzammer, Julian [1 ,2 ,3 ]
von Hundelshausen, Philipp [3 ,4 ]
机构
[1] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Univ Hosp, Dept Cardiol & Angiol, Frankfurt, Germany
[3] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany
[4] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, IPEK, Munich, Germany
关键词
platelet; atherothrombosis; inflammation; leukocyte; red blood cell; endothelial cell; NEUTROPHIL EXTRACELLULAR TRAPS; PLATELET SURFACE EXPRESSION; MIGRATION INHIBITORY FACTOR; ACUTE CORONARY SYNDROME; VON-WILLEBRAND-FACTOR; I RECEPTORS CXCR4; RED-BLOOD-CELLS; ENDOTHELIAL-CELLS; BONE-MARROW; RECOMBINANT PLATELET-FACTOR-4;
D O I
10.3389/fimmu.2023.1276353
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Blood clotting is a finely regulated process that is essential for hemostasis. However, when dysregulated or spontaneous, it promotes thrombotic disorders. The fact that these are triggered, accompanied and amplified by inflammation is reflected in the term thromboinflammation that includes chemokines. The role of chemokines in thrombosis is therefore illuminated from a cellular perspective, where endothelial cells, platelets, red blood cells, and leukocytes may be both the source and target of chemokines. Chemokine-dependent prothrombotic processes may thereby occur independently of chemokine receptors or be mediated by chemokine receptors, although the binding and activation of classical G protein-coupled receptors and their signaling pathways differ from those of atypical chemokine receptors, which do not function via cell activation and recruitment. Regardless of binding to their receptors, chemokines can induce thrombosis by forming platelet-activating immune complexes with heparin or other polyanions that are pathognomonic for HIT and VITT. In addition, chemokines can bind to NETs and alter their structure. They also change the electrical charge of the cell surface of platelets and interact with coagulation factors, thereby modulating the balance of fibrinolysis and coagulation. Moreover, CXCL12 activates CXCR4 on platelets independently of classical migratory chemokine activity and causes aggregation and thrombosis via the PI3K beta and Btk signaling pathways. In contrast, typical chemokine-chemokine receptor interactions are involved in the processes that contribute to the adhesiveness of the endothelium in the initial phase of venous thrombosis, where neutrophils and monocytes subsequently accumulate in massive numbers. Later, the reorganization and resolution of a thrombus require coordinated cell migration and invasion of the thrombus, and, as such, indeed, chemokines recruit leukocytes to existing thrombi. Therefore, chemokines contribute in many independent ways to thrombosis.
引用
收藏
页数:18
相关论文
共 166 条
[21]   Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood [J].
Clark, Stephen R. ;
Ma, Adrienne C. ;
Tavener, Samantha A. ;
McDonald, Braedon ;
Goodarzi, Zahra ;
Kelly, Margaret M. ;
Patel, Kamala D. ;
Chakrabarti, Subhadeep ;
McAvoy, Erin ;
Sinclair, Gary D. ;
Keys, Elizabeth M. ;
Allen-Vercoe, Emma ;
DeVinney, Rebekah ;
Doig, Christopher J. ;
Green, Francis H. Y. ;
Kubes, Paul .
NATURE MEDICINE, 2007, 13 (04) :463-469
[22]  
Clemetson KJ, 2000, BLOOD, V96, P4046
[23]   Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders [J].
Collado, Aida ;
Marques, Patrice ;
Escudero, Paula ;
Rius, Cristina ;
Domingo, Elena ;
Martinez-Hervas, Sergio ;
Real, Jose T. ;
Ascaso, Juan F. ;
Piqueras, Laura ;
Sanz, Maria-Jesus .
CARDIOVASCULAR RESEARCH, 2018, 114 (13) :1764-1775
[24]   Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4 [J].
Collins, Paul J. ;
McCully, Michelle L. ;
Martinez-Munoz, Laura ;
Santiago, Cesar ;
Wheeldon, James ;
Caucheteux, Stephan ;
Thelen, Sylvia ;
Cecchinato, Valentina ;
Laufer, Julia M. ;
Purvanov, Vladimir ;
Monneau, Yoan R. ;
Lortat-Jacob, Hugues ;
Legler, Daniel F. ;
Uguccioni, Mariagrazia ;
Thelen, Marcus ;
Piguet, Vincent ;
Mellado, Mario ;
Moser, Bernhard .
FASEB JOURNAL, 2017, 31 (07) :3084-3097
[25]   Open source system for analyzing, validating, and storing protein identification data [J].
Craig, R ;
Cortens, JP ;
Beavis, RC .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (06) :1234-1242
[26]   Intertwining of thrombosis and inflammation in atherosclerosis [J].
Croce, Kevin ;
Libby, Peter .
CURRENT OPINION IN HEMATOLOGY, 2007, 14 (01) :55-61
[27]   The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial [J].
de Zeeuw, Dick ;
Bekker, Pirow ;
Henkel, Elena ;
Hasslacher, Christopher ;
Gouni-Berthold, Ioanna ;
Mehling, Heidrun ;
Potarca, Antonia ;
Tesar, Vladimir ;
Heerspink, Hiddo J. Lambers ;
Schall, Thomas J. .
LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (09) :687-696
[28]   CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration [J].
Decaillot, Fabien M. ;
Kazmi, Manija A. ;
Lin, Ying ;
Ray-Saha, Sarmistha ;
Sakmar, Thomas P. ;
Sachdev, Pallavi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (37) :32188-32197
[29]   REVERSAL OF HEPARIN ANTICOAGULATION BY RECOMBINANT PLATELET FACTOR-4 IN HUMANS [J].
DEHMER, GJ ;
FISHER, M ;
TATE, DA ;
TEO, S ;
BONNEM, EM .
CIRCULATION, 1995, 91 (08) :2188-2194
[30]   A Case Series of Recombinant Platelet Factor 4 for Heparin Reversal After Cardiopulmonary Bypass [J].
Demma, Linda ;
Levy, Jerrold H. .
ANESTHESIA AND ANALGESIA, 2012, 115 (06) :1273-1278